Covid-19 public health road map: Opioid substitution treatment (OST) adherence

Hannah Family; Angel Chater; Myles-Jay Linton; Neil Howlett; Rosalind Gittins; Lindsey Hines; Jenny Scott; Elizabeth Jenkinson; Vivien Swanson; Tracy Epton; Nicky Knowles; Shanara Abdin; Jo Hart; Atiya Kamal; Lucie Byrne-Davis; Chris Armitage; Madelynne A Arden; Ellie Whittaker; Paul Chadwick; Lesley Lewis; Daryl O'Connor; John Drury; Emily McBride; Gillian Shorter

Covid-19 public health road map: Opioid substitution treatment (OST) adherence

Hannah Family, Angel Chater, Myles-Jay Linton, Neil Howlett, Rosalind Gittins, Lindsey Hines, Jenny Scott, Elizabeth Jenkinson, Vivien Swanson, Tracy Epton, Nicky Knowles, Shanara Abdin, Jo Hart, Atiya Kamal, Lucie Byrne-Davis, Chris Armitage, Madelynne A Arden, Ellie Whittaker, Paul Chadwick, Lesley LewisDaryl O'Connor, John Drury, Emily McBride, Gillian Shorter

School of Psychology

Research output: Book/Report › Commissioned report

Abstract

Behavioural Science Recommendations
Adhering to opioids prescribed as part of OST can benefit both physical and psychological health. OST adherence of those prescribed is influenced by what they know and what they can do (capability); people around them and the physical environment (opportunity); and by beliefs, what they want, how they see themselves, how they regulate emotion, and habit (motivation).

To support changes since COVID-19:
• Facilitate the planning and development of OST services, which enable individuals to receive support and timely access to OST3-7, and offer assertive outreach and virtual consultations where appropriate,
• Continue to liberalise OST dispensing arrangements where appropriate, guided by an individuals' risk assessment which includes risk of diversion, safeguarding, and safe storage arrangements. Providers must communicate effectively with the individual and collaborate on proposed changes to dispensing arrangements to support adherence,
• Where needed, adjust services to facilitate physical-distancing, self-isolating, quality of life, and shielding (if relevant); this may include dispensing larger volumes for self-administration at home, delivery of medication, long-acting formulations, and/or identification of a nominated individual to assist in the collection, management, or safe storage of prescriptions. Support access to digital devices for those receiving mobile or online support,
• Vaccine uptake (including hepatitis B and COVID-19 vaccines) to be encouraged and facilitated8-9,
• Continue harm reduction interventions, holistic, and wrap-around support services10 such as take-home naloxone and needle syringe provision; blood borne virus screening and treatment; psychosocial interventions (including digital and virtual options); advice on self-care, health, and wellbeing; and services to facilitate housing and safe shelter for those who are homeless or vulnerably housed11, or otherwise at risk.

We recommend following the British Psychological Society's Behavioural Science and Disease Prevention: Psychological guidance12 to shape any policy and communications strategy.

Original language	English
Place of Publication	Leicester
Publisher	British Psychological Society
Commissioning body	British Psychological Society
Publication status	Published - 19 Aug 2022

Bibliographical note

Co-Chair of the Health Behaviour and COVID-19 working group that produced these documents 7/9

Keywords

opioid overdose
opioid substitution theory
treatment adherence
behaviour change

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.bps.org.uk/news/three-new-healthcare-road-maps-launched-bps-part-covid-19-behavioural-science-and-disease-0Licence: Unspecified

1 Public lecture/debate/seminar

Academic Expert Panelist on overdose prevention centres event hosted by Extern with screening of the film Love in the time of Fentanyl
Shorter, G. (Invited speaker)
12 Dec 2022
Activity: Talk or presentation types › Public lecture/debate/seminar

6 Commissioned report

The Case for Overdose Prevention Centres: Voices from Sandwell
Southwell, M., Scher, B., Harris, M. & Shorter, G., 31 Jul 2022, London: Drug Science. 68 p.
Research output: Book/Report › Commissioned report

Open Access
File
COVID-19 Public Health Road Map: Eating Behaviour
Whittaker, E., Howlett, N., Abdin, S., Chadwick, P., Shorter, G., Hart, J., Armitage, C., Epton, T., Byrne-Davis, L., Arden, M. A., Kamal, A., Lewis, L., Drury, J., McBride, E., O'Connor, D., Swanson, V., Thompson, S., Chater, A. & Behavioural Science and Disease Prevention Taskforce, 28 Oct 2020, Leicester: British Psychological Society.
Research output: Book/Report › Commissioned report

Open Access
COVID-19 Public Health Road Map: Physical activity
Chater, A., Abdin, S., Dryden, J., Lewis, L., Shorter, G., Arden, M. A., Chadwick, P., Hart, J., Armitage, C., Byrne-Davis, L., Epton, T., Kamal, A., Drury, J., McBride, E., O'Connor, D., Swanson, V., Thompson, S., Whittaker, E., Howlett, N. & Behavioural Science and Disease Prevention Taskforce, 28 Oct 2020, Leicester: British Psychological Society.
Research output: Book/Report › Commissioned report

Open Access

Cite this

Family, H., Chater, A., Linton, M.-J., Howlett, N., Gittins, R., Hines, L., Scott, J., Jenkinson, E., Swanson, V., Epton, T., Knowles, N., Abdin, S., Hart, J., Kamal, A., Byrne-Davis, L., Armitage, C., Arden, M. A., Whittaker, E., Chadwick, P., ... Shorter, G. (2022). Covid-19 public health road map: Opioid substitution treatment (OST) adherence. British Psychological Society. https://www.bps.org.uk/news/three-new-healthcare-road-maps-launched-bps-part-covid-19-behavioural-science-and-disease-0

@book{c2320e5a51a3462e9e17a3f5d06645b1,

title = "Covid-19 public health road map: Opioid substitution treatment (OST) adherence",

abstract = "Behavioural Science RecommendationsAdhering to opioids prescribed as part of OST can benefit both physical and psychological health. OST adherence of those prescribed is influenced by what they know and what they can do (capability); people around them and the physical environment (opportunity); and by beliefs, what they want, how they see themselves, how they regulate emotion, and habit (motivation). To support changes since COVID-19:• Facilitate the planning and development of OST services, which enable individuals to receive support and timely access to OST3-7, and offer assertive outreach and virtual consultations where appropriate,• Continue to liberalise OST dispensing arrangements where appropriate, guided by an individuals' risk assessment which includes risk of diversion, safeguarding, and safe storage arrangements. Providers must communicate effectively with the individual and collaborate on proposed changes to dispensing arrangements to support adherence,• Where needed, adjust services to facilitate physical-distancing, self-isolating, quality of life, and shielding (if relevant); this may include dispensing larger volumes for self-administration at home, delivery of medication, long-acting formulations, and/or identification of a nominated individual to assist in the collection, management, or safe storage of prescriptions. Support access to digital devices for those receiving mobile or online support, • Vaccine uptake (including hepatitis B and COVID-19 vaccines) to be encouraged and facilitated8-9,• Continue harm reduction interventions, holistic, and wrap-around support services10 such as take-home naloxone and needle syringe provision; blood borne virus screening and treatment; psychosocial interventions (including digital and virtual options); advice on self-care, health, and wellbeing; and services to facilitate housing and safe shelter for those who are homeless or vulnerably housed11, or otherwise at risk.We recommend following the British Psychological Society's Behavioural Science and Disease Prevention: Psychological guidance12 to shape any policy and communications strategy.",

keywords = "opioid overdose, opioid substitution theory, treatment adherence, behaviour change",

author = "Hannah Family and Angel Chater and Myles-Jay Linton and Neil Howlett and Rosalind Gittins and Lindsey Hines and Jenny Scott and Elizabeth Jenkinson and Vivien Swanson and Tracy Epton and Nicky Knowles and Shanara Abdin and Jo Hart and Atiya Kamal and Lucie Byrne-Davis and Chris Armitage and Arden, {Madelynne A} and Ellie Whittaker and Paul Chadwick and Lesley Lewis and Daryl O'Connor and John Drury and Emily McBride and Gillian Shorter",

note = "Co-Chair of the Health Behaviour and COVID-19 working group that produced these documents 7/9",

year = "2022",

month = aug,

day = "19",

language = "English",

publisher = "British Psychological Society",

address = "United Kingdom",

}

Family, H, Chater, A, Linton, M-J, Howlett, N, Gittins, R, Hines, L, Scott, J, Jenkinson, E, Swanson, V, Epton, T, Knowles, N, Abdin, S, Hart, J, Kamal, A, Byrne-Davis, L, Armitage, C, Arden, MA, Whittaker, E, Chadwick, P, Lewis, L, O'Connor, D, Drury, J, McBride, E & Shorter, G 2022, Covid-19 public health road map: Opioid substitution treatment (OST) adherence. British Psychological Society, Leicester. <https://www.bps.org.uk/news/three-new-healthcare-road-maps-launched-bps-part-covid-19-behavioural-science-and-disease-0>

TY - BOOK

T1 - Covid-19 public health road map: Opioid substitution treatment (OST) adherence

AU - Family, Hannah

AU - Chater, Angel

AU - Linton, Myles-Jay

AU - Howlett, Neil

AU - Gittins, Rosalind

AU - Hines, Lindsey

AU - Scott, Jenny

AU - Jenkinson, Elizabeth

AU - Swanson, Vivien

AU - Epton, Tracy

AU - Knowles, Nicky

AU - Abdin, Shanara

AU - Hart, Jo

AU - Kamal, Atiya

AU - Byrne-Davis, Lucie

AU - Armitage, Chris

AU - Arden, Madelynne A

AU - Whittaker, Ellie

AU - Chadwick, Paul

AU - Lewis, Lesley

AU - O'Connor, Daryl

AU - Drury, John

AU - McBride, Emily

AU - Shorter, Gillian

N1 - Co-Chair of the Health Behaviour and COVID-19 working group that produced these documents 7/9

PY - 2022/8/19

Y1 - 2022/8/19

N2 - Behavioural Science RecommendationsAdhering to opioids prescribed as part of OST can benefit both physical and psychological health. OST adherence of those prescribed is influenced by what they know and what they can do (capability); people around them and the physical environment (opportunity); and by beliefs, what they want, how they see themselves, how they regulate emotion, and habit (motivation). To support changes since COVID-19:• Facilitate the planning and development of OST services, which enable individuals to receive support and timely access to OST3-7, and offer assertive outreach and virtual consultations where appropriate,• Continue to liberalise OST dispensing arrangements where appropriate, guided by an individuals' risk assessment which includes risk of diversion, safeguarding, and safe storage arrangements. Providers must communicate effectively with the individual and collaborate on proposed changes to dispensing arrangements to support adherence,• Where needed, adjust services to facilitate physical-distancing, self-isolating, quality of life, and shielding (if relevant); this may include dispensing larger volumes for self-administration at home, delivery of medication, long-acting formulations, and/or identification of a nominated individual to assist in the collection, management, or safe storage of prescriptions. Support access to digital devices for those receiving mobile or online support, • Vaccine uptake (including hepatitis B and COVID-19 vaccines) to be encouraged and facilitated8-9,• Continue harm reduction interventions, holistic, and wrap-around support services10 such as take-home naloxone and needle syringe provision; blood borne virus screening and treatment; psychosocial interventions (including digital and virtual options); advice on self-care, health, and wellbeing; and services to facilitate housing and safe shelter for those who are homeless or vulnerably housed11, or otherwise at risk.We recommend following the British Psychological Society's Behavioural Science and Disease Prevention: Psychological guidance12 to shape any policy and communications strategy.

AB - Behavioural Science RecommendationsAdhering to opioids prescribed as part of OST can benefit both physical and psychological health. OST adherence of those prescribed is influenced by what they know and what they can do (capability); people around them and the physical environment (opportunity); and by beliefs, what they want, how they see themselves, how they regulate emotion, and habit (motivation). To support changes since COVID-19:• Facilitate the planning and development of OST services, which enable individuals to receive support and timely access to OST3-7, and offer assertive outreach and virtual consultations where appropriate,• Continue to liberalise OST dispensing arrangements where appropriate, guided by an individuals' risk assessment which includes risk of diversion, safeguarding, and safe storage arrangements. Providers must communicate effectively with the individual and collaborate on proposed changes to dispensing arrangements to support adherence,• Where needed, adjust services to facilitate physical-distancing, self-isolating, quality of life, and shielding (if relevant); this may include dispensing larger volumes for self-administration at home, delivery of medication, long-acting formulations, and/or identification of a nominated individual to assist in the collection, management, or safe storage of prescriptions. Support access to digital devices for those receiving mobile or online support, • Vaccine uptake (including hepatitis B and COVID-19 vaccines) to be encouraged and facilitated8-9,• Continue harm reduction interventions, holistic, and wrap-around support services10 such as take-home naloxone and needle syringe provision; blood borne virus screening and treatment; psychosocial interventions (including digital and virtual options); advice on self-care, health, and wellbeing; and services to facilitate housing and safe shelter for those who are homeless or vulnerably housed11, or otherwise at risk.We recommend following the British Psychological Society's Behavioural Science and Disease Prevention: Psychological guidance12 to shape any policy and communications strategy.

KW - opioid overdose

KW - opioid substitution theory

KW - treatment adherence

KW - behaviour change

M3 - Commissioned report

BT - Covid-19 public health road map: Opioid substitution treatment (OST) adherence

PB - British Psychological Society

CY - Leicester

ER -

Covid-19 public health road map: Opioid substitution treatment (OST) adherence

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Activities

Academic Expert Panelist on overdose prevention centres event hosted by Extern with screening of the film Love in the time of Fentanyl

Research output

The Case for Overdose Prevention Centres: Voices from Sandwell

COVID-19 Public Health Road Map: Eating Behaviour

COVID-19 Public Health Road Map: Physical activity

Cite this